Meinhard Schmidt Appointed as Cellnovo Non-Executive Director

January 09, 2012, Press Dispensary. Cellnovo, the leading innovator in mobile-connected diabetes management, today announced the appointment of Meinhard Schmidt as non-executive director.

Mr Schmidt extends the considerable leadership experience of the Cellnovo board, bringing also a passion for medical and communication technology combined with considerable knowledge of diabetes management. Much of this experience was built during his many years as a senior leader within Roche Diagnostics, where he repeatedly delivered competitive advantage by implementing a culture led by customer need.

“We warmly welcome Meinhard to Cellnovo,” said William McKeon, Cellnovo CEO. “He brings considerable relevant experience to the board and long experience of effective commercialisation. Meinhard is a great fit for the company; his insight and expertise will be crucial as we launch the world’s first mobile-connected diabetes management system.”

“The Cellnovo team has freed itself from historical concepts of diabetes management, and has developed a system, with mobile connectivity, that puts the patient at the heart of enhanced control while eliminating the principal burdens of self-management.” added Mr Schmidt, ”I am delighted to be joining Cellnovo’s board, and to be joining a team that has turned an ideal into a practical system that will improve the lives and care of thousands of diabetes patients.”

- ends -

Notes for editors

About Cellnovo

Cellnovo is a mobile medical device company based in London, UK. The company was built by a seasoned group of veterans from both the medical device and mobile communications industries. Together, they have developed a mobile health system designed to reduce burden and provide more insight to people with diabetes, their healthcare teams and families.

The number of people with diabetes is estimated to double in the next twenty years, placing a tremendous strain on all healthcare systems throughout the world. The Cellnovo mobile diabetes management system is transformational in that it provides real-time access to patient data and the opportunity to streamline and improve care while at the same time reduce costs.
For more information, please visit http://www.cellnovo.com

FOR FURTHER INFORMATION PLEASE CONTACT
William McKeon, Chief Executive Officer
Cellnovo Ltd.
Tel: + 44 (0) 2077 486940
Email:
Site: www.cellnovo.com